RxDoctor Payments Data

Emil Abdulhayoglu, MD

Nephrology · Brandon, FLNPI 1801860671

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 63.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $2,296 and has fallen 94.8% since, to $119 in 2025.

$7,870in general payments, 2019–2025

Across 150 payments — averaging $52.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Merit Medical Systems Inc$996
  • Mozarc Medical US LLC$875
  • Amgen$427
  • Akebia Therapeutics Inc$158
  • Mallinckrodt Enterprises LLC$106
  • plus $353 from 8 others

What the payments were for

  • Travel & lodging$3,20841%
  • Food & beverage$4,62459%
  • Education$380%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,870 in reported general payments places this provider in the 85th percentile of 756 nephrology providers in Florida.

See all nephrology providers in Florida →

Medicare billing

Part B allowed, 2024
$403,201
Medicare patients
125
Services billed
1,699

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Brandon

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →